StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)

Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%

Eli Lilly pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Eli Lilly's pe ratio was 48.2× on Nov 11, 2026, against 52.6× a year earlier. Over the last 5 years it ranged from 37.4× to 134.7×, with a median of 56.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202648.2×−4.3
2025Dec 31, 202552.6×−30.9
2024Dec 31, 202483.5×−22.1
2023Dec 29, 2023105.6×+50.6
2022Dec 30, 202255.0×+12.9
2021Dec 31, 202142.1×+14.5
2020Dec 31, 202027.6×+11.6
2019Dec 31, 201916.0×−241.2
2018Dec 31, 2018257.2×+217.1
2017Dec 29, 201740.0×+8.0
2016Dec 30, 201632.0×−6.1
2015Dec 31, 201538.1×+22.2
2014Dec 31, 201416.0×+2.2
2013Jan 31, 201313.8×+1.1
2012Dec 31, 201212.6×–

More Eli Lilly figures

See a number that looks wrong?